Riskpilot← Back to searchSign inGet full accessTermino C 13910 AB
ABDissolvedOrg 5561361469Manufacture of medical and dental instruments and supplies · NACE 3250Est. 19700 employees
Revenue 2024
—
EBITDA margin
—
+44% vs 2023
Equity ratio
94.4%
Financial strength
Net profit 2024
SEK -173K
-169% vs 2023
| Revenue | — | — |
| EBITDA | SEK -184K | +44% |
| Net profit | SEK -173K | -169% |
| Total assets | SEK 250K | -60% |
| Equity | SEK 236K | -61% |
| Employees | 0 | — |
Legal name
Termino C 13910 AB
Org number
5561361469
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
1 juni 1970
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Phone
+4636140900
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | — |
| Staff expenses | — | — | — | −169 | −170 |
| EBITDA | −38 | −39 | −217 | −327 | −184 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −38 | −39 | −217 | −327 | −184 |
| Net financials | 806 | 1 011 | 149 | 579 | 11 |
| Profit before tax | 517 | 712 | −67 | 251 | −173 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | 517 | 712 | −67 | 251 | −173 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 727 | 1 091 | 768 | 624 | 250 |
| Equity | 676 | 1 039 | 741 | 603 | 236 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 51 | 53 | 26 | 22 | 14 |
| Total debt | 51 | 53 | 26 | 22 | 14 |
EBITDA margin
-18360700.0%
This company
15.8%
Market median
-116207062% vs market
20202024
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20202024
Return on equity
-73.4%
This company
18.4%
Market median
-499% vs market
20202024
Net profit margin
-17303300.0%
This company
8.1%
Market median
-213621088% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
GE Chief Auditor | Chief Auditor | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Termino C 13910 AB 
Termino c 9039 ABBoard members of Termino C 13910 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnar Erik Kristoffer Johansson | Chief Auditor | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Morgan Svensson | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Jan Axel Svensson | Board of Directors | 0 companies |